2012 Pharmaceutical Diversification Trends, Egypt & Saudi Arabia Pharmaceutical Markets Analyzed in New Research Reports

DALLAS, June 28, 2012 /PRNewswire/ --

ReportsnReports.com adds following new Pharmaceutical market research reports for Egypt & Saudi Arabia as well as Pharmaceutical Diversification Trends for 2012:

A.  Pharmaceutical Diversification Trends 2012

Pharmaceutical companies are facing unprecedented pressures including revenue loss due to the patent cliff and growing healthcare cost containment measures introduced in most developed markets. As a result, they have been forced to reassess their strategies, with diversification beyond branded small molecule products and branded pharmaceuticals in general representing an obvious route.

Features and benefits

• Analysis of the historical merger, acquisition and divestment trends of the top 10 pharmaceutical companies.
• Insight into the main diversification strategies employed by pharma, as well as analysis of the top 10 sectors pharma is diversifying into.
• Case study analysis comparing and contrasting the diversification strategies of the top 10 pharma companies.

Highlights

The branded prescription pharma sector is the most profitable healthcare sector. Provided that profit margins associated with innovative drug development remain high, pharma companies that have been successful in replenishing their pipelines with new drugs that lead to successful launches can do no better than to stick with what they do best.

While the innovation-driven diversification results in greater profitability, companies facing an imminent revenue drop due to weak launch portfolios are turning towards de-risking diversification, which enables them to close the revenue gap by entering low risk sectors such as consumer health and generics.

Divestment deals have been dominated by pharma's strategy to strip out manufacturing in order to become more focused on R&D and marketing, as well as to cut costs, while divestments in other non-pharma sectors have largely involved the sale of certain assets rather than the divestment of an entire unit or exit from a particular sector altogether.

Request A Sample, Inquire before buying or Buy your copy of the report @http://www.reportsnreports.com/reports/169854-pharmaceutical-diversification-trends-2012.html.

B.  The Pharmaceutical Market in Egypt

The report analyzes the macroeconomic and political situation in Egypt. It covers the healthcare system, and major causes of disease and mortality. It focuses on pharmaceuticals, including their regulation, pricing, intellectual property rights, and counterfeits. It examines pharmaceutical sales, manufacturing, trade, and major multinationals and local companies.

Features and benefits

• Understand the key pharmaceutical market characteristics, including total market size, growth drivers and resistors and overall market attractiveness.
• Evaluate the latest political situation and healthcare reforms and how they impact the pharmaceutical market.
• Develop an understanding of the intellectual property and regulatory environment and how these can affect your product launch strategy.
• Gain insight into controversial pricing issues, which have held back prices and hit profits.
• Assess the major domestic and overseas pharma companies active in Egypt.

Highlights

The Egyptian pharmaceutical market is focused on generics. Per capita spending is low, but the large population means overall sales are worth around $3bn. Out-of-pocket expenditure accounts for around 75% of pharmaceutical sales. In the long term, increasing affluence and universal health insurance will boost sales.

Historically, intellectual property rights were not enforced, and firms were able to register generics/copies using data from the originator companies. Despite some changes, Egypt is on the Watch List of the US Trade Representative due to inadequate enforcement. This means that companies have been slow to introduce new products.

Egypt has certain key differences from many other markets. For example, the data protection period for drugs is five years from when the registration application is filed, rather than from the date of market authorization.

Request A Sample, Inquire before buying or Buy your copy of this report @http://www.reportsnreports.com/reports/169855-the-pharmaceutical-market-in-egypt.html.

C.  The Pharmaceutical Market in Saudi Arabia

The report forecasts the Saudi Arabian pharmaceutical market to 2017, set in the context of its macroeconomic environment and healthcare system. Regulatory systems, distribution networks, and pricing and reimbursement arrangements are examined in detail. The report also provides profiles of the leading companies, incorporating their product portfolios and growth strategies in Saudi Arabia.

Features and benefits

• Plan your company's strategy for Saudi Arabia by assessing factors driving and restraining market growth.
• Understand the dynamics between innovative drugs and generics and how this could affect your business plan.
• Forecast the market to 2017, with separate coverage of generic and patented markets.
• Assess which multinational companies already have a strong market presence and gain valuable insight from their success.
• Develop an understanding of the intellectual property and regulatory environment and how these can affect your product launch strategy.

Highlights

Saudi Arabia has a national health system which provides free healthcare services to all Saudi citizens and expatriates working in the public sector.

In addition to receiving pricing advantages, the local generics industry is supported by the government through incentives of free land, interest-free loans and a 10% subsidy to the production cost of medicines and pharmaceutical products. Pharmacoeconomic assessments are being phase in to inform approval and pricing decisions.

Drivers of drug volume demand will be an increasing and aging population, as well as the rising prevalence of major civilization diseases such as diabetes and cardiovascular problems, which require long-term treatment.

Request A Sample, Inquire before buying or Buy your copy of this report @ http://www.reportsnreports.com/reports/169857-the-pharmaceutical-market-in-saudi-arabia.html.

More Pharmaceutical Market Research Reports @ http://www.reportsnreports.com/market-research/pharmaceuticals/.

Find newly published market research reports for other industries @http://www.reportsnreports.com/latest-market-research.aspx.

About Us:

ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 175,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Contact:
Priyank Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
[email protected]
Explore Company Profiles, SWOT Analysis Reports, Micro Markets & Country specific reports @ http://www.marketreportsonline.com/.

SOURCE ReportsnReports